Literature DB >> 15626013

Analysis of pediatric thrombotic patients in Turkey.

Hale Oren1, Omer Devecioğlu, Mehmet Ertem, Canan Vergin, Kaan Kavakli, Adalet Meral, Duran Canatan, Hayri Toksoy, Incï Yildiz, Emin Kürekçi, Unsal Ozgen, Haldun Oniz, Aytemiz Gürgey.   

Abstract

This study analyzes the data of thrombotic children who were followed up in different pediatric referral centers of Turkey, to obtain more general data on the diagnosis, risk factors, management, and outcome of thrombosis in Turkish children. A simple two-page questionnaire was distributed among contact people from each center to standardize data collection. Thirteen pediatric referral centers responded to the invitation and the total number of cases was 271. All children were diagnosed with thromboembolic disease between January 1995 and October 2001. Median age at time of first thrombotic event was 7.0 years. Of the children 4% of the cases were neonates, 12% were infants less than 1 year old, and 17% were adolescents. Thromboembolic event was mostly located in the cerebral vascular system (32%), deep venous system of the limbs, femoral and iliac veins (24%), portal veins (10%), and intracardiac region (9%). Acquired risk factors were present in 86% of the children. Infection was the most common underlying risk factor. Inherited risk factors were present in 30% of the children. FVL was the most common inherited risk factor. Acquired and inherited risk factors were present simultaneously in 19% of the patients. Eleven children had a history of familial thrombosis. Due to the local treatment preferences, the treatment of the children varied greatly. Outcome of the 142 patients (52%) was reported: 88 (62%) patients had complete resolution, 47 (33%) had complications, 12 (9%) had recurrent thrombosis, and 34 (24%) died. Three children (2.1%) died as a direct consequence of their thromboembolic disease. The significant morbidity and mortality found in this study supports the need for multicentric prospective clinical trials to obtain more generalizable data on management and outcome of thrombosis in Turkish children.

Entities:  

Mesh:

Year:  2004        PMID: 15626013     DOI: 10.1080/08880010490500935

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  2 in total

1.  Thrombolysis with Systemic Recombinant Tissue Plasminogen Activator in Children: A Multicenter Retrospective Study

Authors:  Emine Zengin; Nazan Sarper; Arzu Yazal Erdem; Işık Odaman Al; Melike Sezgin Evim; Neşe Yaralı; Burcu Belen; Arzu Akçay; Ayşen Türedi Yıldırım; Tuba Hilkay Karapınar; Adalet Meral Güneş; Sema Aylan Gelen; Hale Ören; Lale Olcay; Birol Baytan; Hüseyin Gülen; Gülyüz Öztürk; Mehmet Fatih Orhan; Yeşim Oymak; Sibel Akpınar; Özlem Tüfekçi; Meryem Albayrak; Burçak Tatlı Güneş; Aylin Canpolat; Namık Özbek
Journal:  Turk J Haematol       Date:  2021-08-25       Impact factor: 1.831

Review 2.  Thrombosis Prevention and Anticoagulation Management in the Pediatric Patient with Congenital Heart Disease.

Authors:  Eman Abdelghani; Clifford L Cua; Jean Giver; Vilmarie Rodriguez
Journal:  Cardiol Ther       Date:  2021-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.